Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy.

Leary M, Heerboth S, Lapinska K, Sarkar S.

Cancers (Basel). 2018 Dec 4;10(12). pii: E483. doi: 10.3390/cancers10120483. Review.

2.

Cancer Progenitor Cells: The Result of an Epigenetic Event?

Lapinska K, Faria G, McGonagle S, Macumber KM, Heerboth S, Sarkar S.

Anticancer Res. 2018 Jan;38(1):1-6. Review.

PMID:
29277749
3.

The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells.

Lapinska K, Housman G, Byler S, Heerboth S, Willbanks A, Oza A, Sarkar S.

Anticancer Res. 2016 Nov;36(11):5731-5742.

PMID:
27793894
4.

The Evolution of Epigenetics: From Prokaryotes to Humans and Its Biological Consequences.

Willbanks A, Leary M, Greenshields M, Tyminski C, Heerboth S, Lapinska K, Haskins K, Sarkar S.

Genet Epigenet. 2016 Aug 3;8:25-36. doi: 10.4137/GEG.S31863. eCollection 2016. Review.

5.

A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis.

Longacre M, Snyder NA, Housman G, Leary M, Lapinska K, Heerboth S, Willbanks A, Sarkar S.

Int J Mol Sci. 2016 May 18;17(5). pii: E759. doi: 10.3390/ijms17050759. Review.

6.

EMT and tumor metastasis.

Heerboth S, Housman G, Leary M, Longacre M, Byler S, Lapinska K, Willbanks A, Sarkar S.

Clin Transl Med. 2015 Feb 26;4:6. doi: 10.1186/s40169-015-0048-3. eCollection 2015.

7.

Use of epigenetic drugs in disease: an overview.

Heerboth S, Lapinska K, Snyder N, Leary M, Rollinson S, Sarkar S.

Genet Epigenet. 2014 May 27;6:9-19. doi: 10.4137/GEG.S12270. eCollection 2014. Review.

8.

Drug resistance in cancer: an overview.

Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, Sarkar S.

Cancers (Basel). 2014 Sep 5;6(3):1769-92. doi: 10.3390/cancers6031769. Review.

9.

Do epigenetic drug treatments hold the key to killing cancer progenitor cells?

Byler S, Sarkar S.

Epigenomics. 2014 Apr;6(2):161-5. doi: 10.2217/epi.14.4. No abstract available.

PMID:
24811783
10.

Genetic and epigenetic aspects of breast cancer progression and therapy.

Byler S, Goldgar S, Heerboth S, Leary M, Housman G, Moulton K, Sarkar S.

Anticancer Res. 2014 Mar;34(3):1071-7. Review.

PMID:
24596345
11.

MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression.

Patel K, Kollory A, Takashima A, Sarkar S, Faller DV, Ghosh SK.

Cancer Lett. 2014 May 28;347(1):54-64. doi: 10.1016/j.canlet.2014.01.020. Epub 2014 Jan 31.

12.

Cancer development, progression, and therapy: an epigenetic overview.

Sarkar S, Horn G, Moulton K, Oza A, Byler S, Kokolus S, Longacre M.

Int J Mol Sci. 2013 Oct 21;14(10):21087-113. doi: 10.3390/ijms141021087. Review.

13.

Enhanced cytotoxicity from deoxyguanosine-enriched T-oligo in prostate cancer cells.

Rankin AM, Forman L, Sarkar S, Faller DV.

Nucleic Acid Ther. 2013 Oct;23(5):311-21. doi: 10.1089/nat.2013.0420. Epub 2013 Aug 24.

14.

Telomere-homologous G-rich oligonucleotides sensitize human ovarian cancer cells to TRAIL-induced growth inhibition and apoptosis.

Sarkar S, Faller DV.

Nucleic Acid Ther. 2013 Jun;23(3):167-74. doi: 10.1089/nat.2012.0401. Epub 2013 May 2.

15.

Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy.

Sarkar S, Goldgar S, Byler S, Rosenthal S, Heerboth S.

Epigenomics. 2013 Feb;5(1):87-94. doi: 10.2217/epi.12.68. Review.

PMID:
23414323
16.

Anti-breast cancer effects of histone deacetylase inhibitors and calpain inhibitor.

Mataga MA, Rosenthal S, Heerboth S, Devalapalli A, Kokolus S, Evans LR, Longacre M, Housman G, Sarkar S.

Anticancer Res. 2012 Jul;32(7):2523-9.

PMID:
22753709
17.

Mechanism of T-oligo-induced cell cycle arrest in Mia-PaCa pancreatic cancer cells.

Rankin AM, Sarkar S, Faller DV.

J Cell Physiol. 2012 Jun;227(6):2586-94. doi: 10.1002/jcp.22997.

18.

Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling.

Sarkar S, Abujamra AL, Loew JE, Forman LW, Perrine SP, Faller DV.

Anticancer Res. 2011 Sep;31(9):2723-32.

PMID:
21868513
19.

T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells.

Sarkar S, Faller DV.

Oligonucleotides. 2011 Feb;21(1):47-53. doi: 10.1089/oli.2010.0259. Epub 2011 Jan 31.

20.

A vitamin D receptor-alkylating derivative of 1α,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth.

Lambert JR, Eddy VJ, Young CD, Persons KS, Sarkar S, Kelly JA, Genova E, Lucia MS, Faller DV, Ray R.

Cancer Prev Res (Phila). 2010 Dec;3(12):1596-607. doi: 10.1158/1940-6207.CAPR-10-0122.

Supplemental Content

Loading ...
Support Center